Augmenting the clearance of bacterial products to reduce systemic inflammation.


Driven by the knowledge that better outcomes in SEPSIS are possible, Cyon Therapeutics Inc. was formed in 2014 to make this a reality. Led by a team of outstanding Critical Care Physicians and support by 2 CEOs, the goal of the organisation is to bring a novel treatment platform to sepsis. Through their groundbreaking scientific discoveries the team is developing the means to boost the body’s natural ability to clear infectious toxins from the bloodstream.

Go to Top of Page